Product introduction
Xostiv 250mg Tablet is used in the treatment of cancer of the prostate gland. It may also be used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy.
Xostiv 250mg Tablet should be taken on an empty stomach, either one hour before or at least two hours after a meal. Taking it with food may increase the blood levels of Xostiv 250mg Tablet, which may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to.
The most common side effects of Xostiv 250mg Tablet include vomiting, decreased potassium level in blood, edema (swelling), decreased white blood cell count, and fatigue. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Other than this, the yellowing of the skin, loss of appetite, shortness of breath, dark urine, and nausea can happen, which indicate some liver problems. Your doctor might check you for liver function, blood pressure, and the level of potassium in your blood.
Before taking Xostiv 250mg Tablet, tell your doctor if you have high blood pressure, heart problems, liver or kidney problems, or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medication, so let your doctor know about all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. It may harm your baby. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You may be asked to undergo regular monitoring of your blood glucose level while on treatment.
Uses of Xostiv Tablet
- Prostate cancer
Benefits of Xostiv Tablet
In Prostate cancer
Side effects of Xostiv Tablet
Common side effects of Xostiv
- Edema (swelling)
- Vomiting
- Decreased potassium level in blood
- Fatigue
- Anemia (low number of red blood cells)
- Urinary tract infection
- Diarrhea
- High blood pressure
- Cough
- Joint swelling
- Nausea
- Hot flashes
- Headache
- Increased glucose level in blood
How to use Xostiv Tablet
How Xostiv Tablet works
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver
What if you forget to take Xostiv Tablet?
Quick tips
- Xostiv 250mg Tablet is usually taken with another medicine called prednisolone to reduce unwanted side effects.
- It should be taken on an empty stomach, either one hour before or at least two hours after a meal.
- Always use effective birth control measures to prevent pregnancy while taking this medicine.
- Your doctor may regularly monitor your liver function, blood pressure, and the level of potassium in your blood while you are having treatment with this medicine.
FAQs
How to take Xostiv 250mg Tablet?
Can Xostiv 250mg Tablet cure prostate cancer?
Is Xostiv 250mg Tablet a chemotherapy drug?
Why do I need to take prednisolone with Xostiv 250mg Tablet?
Does Xostiv 250mg Tablet affect liver?
How frequently should the liver investigations be done?
References:-
Official Regulatory & Clinical Sources for Abiraterone Acetate
-
EMA – Zytiga (Original Brand, Abiraterone Acetate Tablets 250 mg & 500 mg)
European Public Assessment Report (EPAR) detailing indications (mCRPC), dosage instructions (1,000 mg daily on an empty stomach), mechanism of action, and regulatory evaluation.
https://www.ema.europa.eu/en/medicines/human/EPAR/zytiga
European Medicines Agency (EMA) -
EMA – Abiraterone Accord (Generic Equivalent)
EPAR summary for a generic version of Zytiga, confirming bioequivalence, therapeutic use, and dosing guidance.
https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-accord
European Medicines Agency (EMA) -
EMA – Abiraterone Mylan (Another Generic)
Official generic product evaluation showing interchangeable use with Zytiga, approved EU indications, and prescribing direction (1,000 mg daily empty stomach).
https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-mylan
European Medicines Agency (EMA) -
EMA – Product-Specific Bioequivalence Guidance (Abiraterone Acetate 250 mg & 500 mg)
Technical document outlining bioequivalence study requirements for generics matching original formulations.
https://www.ema.europa.eu/en/abiraterone-acetate-product-specific-bioequivalence-guidance
European Medicines Agency (EMA) -
FDA – Approval for Use in High-Risk Metastatic Castration-Sensitive Prostate Cancer
FDA press release (Feb 7, 2018) authorizing abiraterone acetate (Zytiga) plus prednisone for newly diagnosed high-risk metastatic CSPC, approving 1,000 mg daily dosing.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-abiraterone-acetate-combination-prednisone-high-risk-metastatic-castration-sensitive
Reviews
There are no reviews yet.